William J. Bosche

Frederick National Laboratory for Cancer Research

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Cytomegaloviral determinants of CD8 + T cell programming and RhCMV/SIV vaccine efficacy”.

Cytomegaloviral determinants of CD8 + T cell programming and RhCMV/SIV vaccine efficacy

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.30.321349

N/A

0DataRank · unranked

3 citations

Scott G. Hansen, Meaghan H. Hancock, Colette M. Hughes, Julia C. Ford, Roxanne M. Gilbride +25 more

Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy

Science(2021)10.1126/science.abe9233

N/A

0DataRank · unranked

60 citations

Scott G. Hansen, Ravi Iyer, Nessy John, Daniel Malouli, David Morrow +21 more

Cytomegaloviral determinants of CD8 + T cell programming and RhCMV/SIV vaccine efficacy

Science Immunology(2021)10.1126/sciimmunol.abg5413

N/A

0DataRank · unranked

55 citations

Scott G. Hansen, Meaghan H. Hancock, Colette M. Hughes, Julia C. Ford, Roxanne M. Gilbride +25 more

Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy

PLoS Pathogens(2021)10.1371/journal.ppat.1009278

N/A

0DataRank · unranked

32 citations

Scott G. Hansen, G. Lynn Law, Connor Driscoll, Richard Green, Elise Smith +33 more

Antibody-mediated depletion of viral reservoirs is limited in SIV-infected macaques treated early with antiretroviral therapy

Journal of Clinical Investigation(2021)10.1172/jci142421

N/A

0DataRank · unranked

23 citations

Taina T. Immonen, Kelli Oswald, Cathi Pyle, James A. Thomas, William J. Bosche +22 more

Sustained IL-15 response signature predicts RhCMV/SIV vaccine efficacy

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.11.426199

N/A

0DataRank · unranked

1 citations

Scott G. Hansen, G. Lynn Law, Connor Driscoll, Richard Green, Elise Smith +33 more

Myeloid cell tropism enables MHC-E–restricted CD8 + T cell priming and vaccine efficacy by the RhCMV/SIV vaccine

Science Immunology(2022)10.1126/sciimmunol.abn9301

N/A

0DataRank · unranked

40 citations

Meaghan H. Hancock, Daniel Malouli, Emily E. Marshall, Colette M. Hughes, Kurt T. Randall +24 more

Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir

PLoS Pathogens(2024)10.1371/journal.ppat.1012135

N/A

0DataRank · unranked

20 citations

Afam A. Okoye, Christine M. Fennessey, Benjamin Varco-Merth, Taina T. Immonen, Emek Köse +23 more

Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence

PLoS Pathogens(2024)10.1371/journal.ppat.1012496

N/A

0DataRank · unranked

3 citations

Morgan Chaunzwa, Derick M. Duell, Alejandra Marenco, William Goodwin, Rachel Dannay +24 more

Identification of initial sites of SIV rebound after treatment cessation

Research Square(2025)10.21203/rs.3.rs-6814218/v1

N/A

0DataRank · unranked

2 citations

Brandon F. Keele, Afam A. Okoye, Taina T. Immonen, Benjamin Varco-Merth, Derick M. Duell +23 more

The TLR7 agonist vesatolimod does not measurably induce SIV expression in macaques receiving combination antiretroviral therapy initiated during chronic infection

Antimicrobial Agents and Chemotherapy(2025)10.1128/aac.01073-25

N/A

0DataRank · unranked

0 citations

Kelli Oswald, Randy Fast, Rebecca Shoemaker, James Thomas, Cathi Pyle +12 more